Thyroid cancer represents approximately 1% of all human malignancies. papillary thyroid
carcinoma (PTC) is the most common malignant tumor of the thyroid gland, accounting for …

E-cadherin and catenins play a major role in neoplastic cell behavior as a suppressor of
invasion and/or metastasis. The aim of this study was to determine E-cadherin, α-catenin …

Aims: To study cyclooxygenase‐2 (COX‐2) and matrix metalloproteinase‐2 (MMP‐2)
expression in papillary thyroid cancer (PTC). Expression of COX‐2 is elevated in various …

Objective: To assess usefulness of cytokeratin 19 (CK19), thyroperoxidase (TPO), Hector
Battifora mesothelial epitope-1 (HBME-1) and galectin-3 (GAL3) in evaluation of aggressive …

Background: Although papillary thyroid cancer (PTC) is among the most curable cancer
types, it can be a distressing disease for those patients suffering from frequent recurrences …

AIMS: To evaluate the expression of E-cadherin, its association with various
clinicopathological features and its possible relation with distant metastasis-free survival …

Human papillary thyroid cancer (PTC) is often associated with Hashimoto's thyroiditis (HT),
and their coexistence improves the prognosis of PTC. Aim of the study. The objective of our …

Thyroid carcinomas constitute lesions with an ascending incidence, for which many
prognosis assessment systems were developed. This study focused on analyzing the …

Objective To measure the levels of cyclo-oxygenase (COX)-2, matrix metalloproteinase
(MMP)-9 and vascular endothelial growth factor (VEGF) immunostaining in papillary thyroid …

Although papillary thyroid microcarcinoma (PTMC) has an excellent prognosis, certain
cases exhibit aggressive clinical manifestations. In this study, we assessed the expression of …